Emery-Dreifuss muscular dystrophy is a disorder that causes muscles weakness primarily in skeletal and cardiac muscles. In most cases, Emery-Dreifuss muscular dystrophy is caused by mutations in the X-linked EMD gene, so this condition affects more males than females. Early symptoms of Emery-Dreifuss muscular dystrophy include joint deformities involving the elbows, ankles, and neck, and progressive muscles weakening. Most individuals with the disorder have heart complications by the time they reach adulthood. There is no cure or prevention technique for Emery-Dreifuss muscular dystrophy, but the disorder can be managed with physical therapy and can be improved with gene therapy.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Dystrophy, Emery-dreifuss below!
For more information on how to use Laverne, please read the How to Guide.
We have 1390 products for the study of Muscular Dystrophy, Emery-dreifuss that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Muscular Dystrophy, Emery-dreifuss is also known as Emery-dreifuss Muscular Dystrophy, Emery-dreifuss Syndrome.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.